DOCSLIB.ORG

West Nile Virus, Malaria, Dengue Fever January – December 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
West Nile Virus, Malaria, Dengue Fever January – December 2011 Listed for Impact Factor Europe’s journal on infectious disease epidemiology, prevention and control Istockphoto © Special edition: West Nile virus, malaria, dengue fever January – December 2011 This special edition of Eurosurveillance presents a presents articles related to the emergence and re-emergence of West Nile virus infections, malaria and dengue fever in some Mediterranean and other southern European countries. A mix of surveillance reports, case reports and results from laboratory studies provide insight into recent outbreaks in 2011 and overviews on the epidemiological situation since 2005. www.eurosurveillance.org Editorial team Editorial board Based at the European Centre for Austria: Reinhild Strauss, Vienna Disease Prevention and Control (ECDC), Belgium: Koen De Schrijver, Antwerp 171 83 Stockholm, Sweden Belgium: Sophie Quoilin, Brussels Telephone number Bulgaria: Mira Kojouharova, Sofia +46 (0)8 58 60 11 38 or +46 (0)8 58 60 11 36 Croatia: Borislav Aleraj, Zagreb Fax number Cyprus: Chrystalla Hadjianastassiou, Nicosia +46 (0)8 58 60 12 94 Czech Republic: Bohumir Križ, Prague Denmark: Peter Henrik Andersen, Copenhagen E-mail England and Wales: Neil Hough, London [email protected] Estonia: Kuulo Kutsar, Tallinn Editor-in-Chief Finland: Outi Lyytikäinen, Helsinki Ines Steffens France: Judith Benrekassa, Paris Germany: Jamela Seedat, Berlin Scientific Editors Greece: Rengina Vorou, Athens Kathrin Hagmaier Hungary: Ágnes Csohán, Budapest Williamina Wilson Iceland: Haraldur Briem, Reykjavik Karen Wilson Ireland: Lelia Thornton, Dublin Assistant Editors Italy: Paola De Castro, Rome Alina Buzdugan Latvia: Jurijs Perevoščikovs, Riga Ingela Söderlund Lithuania: Milda Zygutiene, Vilnius Associate Editors Luxembourg: Robert Hemmer, Luxembourg Andrea Ammon, Stockholm, Sweden The FYR of Macedonia: Elisaveta Stikova, Skopje Tommi Asikainen, Frankfurt, Germany Malta: Tanya Melillo Fenech, Valletta Mike Catchpole, London, United Kingdom Netherlands: Paul Bijkerk, Bilthoven Denis Coulombier, Stockholm, Sweden Norway: Hilde Klovstad, Oslo Christian Drosten, Bonn, Germany Poland: Malgorzata Sadkowska-Todys, Warsaw Johan Giesecke, Stockholm, Sweden Portugal: TBC, Lisbon Herman Goossens, Antwerp, Belgium Romania: Daniela Pitigoi, Bucharest David Heymann, London, United Kingdom Scotland: Norman Macdonald, Glasgow Irena Klavs, Ljubljana, Slovenia Slovakia: Lukáš Murajda, Martin Karl Kristinsson, Reykjavik, Iceland Slovenia: Alenka Kraigher, Ljubljana Daniel Lévy-Bruhl, Paris, France Spain: Elena Rodríguez Valín, Madrid Richard Pebody, London, United Kingdom Sweden: TBC, Stockholm Panayotis T. Tassios, Athens, Greece Turkey: Aysegul Gozalan, Istanbul Hélène Therre, Paris, France European Commission: Paolo Guglielmetti, Luxembourg Henriette de Valk, Paris, France World Health Organization Regional Office for Europe: Nedret Emiroglu, Copenhagen Sylvie van der Werf, Paris, France Design / Layout Fabrice Donguy / Oudomphone Bounyavong www.eurosurveillance.org © Eurosurveillance, 2011 Contents Special edition: West Nile virus, malaria, Human case of autochthonous West Nile virus dengue fever lineage 2 infection in Italy, September 2011 45 by P Bagnarelli, K Marinelli, D Trotta, A Monachetti, M Tavio, R Del Gobbo, MR Capobianchi, S Menzo, L Nicoletti, F Magurano, PE Varaldo West Nile virus Surveillance and outbreak reports Malaria Prevalence of IgM and IgG antibodies to West Nile Rapid communications virus among blood donors in an affected area of north-eastern Italy, summer 2009 2 Autochthonous Plasmodium vivax malaria in by P Pezzotti, C Piovesan, L Barzon, R Cusinato, M Cattai, Greece, 2011 49 M Pacenti, A Piazza, E Franchin, S Pagni, S Bressan, T Martello, R Potenza, C Scipioni, R Ammendola, A Breda, G by K Danis, A Baka, A Lenglet, W Van Bortel, I Terzaki, M Palù, F Russo, G Rezza Tseroni, M Detsis, E Papanikolaou, A Balaska, S Gewehr, G Dougas, T Sideroglou, A Economopoulou, N Vakalis, S Surveillance of West Nile virus Disease, Tel Aviv Tsiodras, S Bonovas, J Kremastinou District, Israel, 2005 to 2010 7 Plasmodium vivax malaria in a Romanian traveller by E Kopel, Z Amitai, H Bin, LM Shulman, E Mendelson, R Sheffer returning from Greece, August 2011 54 Human cases of West Nile virus Infection in by SA Florescu, CP Popescu, P Calistru, E Ceausu, M Nica, A north-eastern Italy, 15 June to 15 November 2010 14 Toderan, M Zaharia, P Parola by L Barzon, M Pacenti, R Cusinato, M Cattai, E Franchin, S Malaria among patients and aid workers Pagni, T Martello, S Bressan, L Squarzon, AM Cattelan, G consulting a primary healthcare centre in Leogane, Pellizzer, P Scotton, A Beltrame, F Gobbi, Z Bisoffi, F Russo, G Palù Haiti, November 2010 to February 2011 – a prospective observational study 57 Rapid communications by A Neuberger, O Zaulan, S Tenenboim, S Vernet, R Pex, K Held, M Urman, K Garpenfeldt, E Schwartz Outbreak of West Nile virus infection in humans, Romania, July to October 2010 19 by A Sirbu, CS Ceianu, RI Panculescu-Gatej, A Vázquez, A Tenorio, R Rebreanu, M Niedrig, G Nicolescu, A Pistol Dengue fever Increasing West Nile virus antibody titres in Rapid communications central European plasma donors from 2006 to 2010 24 by PO Rabel, CB Planitzer, MR Farcet, KK Orlinger, R Ilk, PN Autochthonous dengue fever in Croatia, August– Barrett, TR Kreil September 2010 59 Molecular detection and phylogenetic analysis of by I Gjenero-Margan, B Aleraj, D Krajcar, V Lesnikar, A West Nile virus lineage 2 in sedentary wild birds Klobučar, I Pem-Novosel, S Kurečić-Filipović, S Komparak, R Martić, S Đuričić, L Betica-Radić, J Okmadžić, T Vilibić- (Eurasian magpie), Greece, 2010 29 Čavlek, A Babić-Erceg, B Turković, T Avšić-Županc, I Radić, by G Valiakos, A Touloudi, C Iacovakis, L Athanasiou, P M Ljubić, K Šarac, N Benić, G Mlinarić-Galinović Birtsas, V Spyrou, C Billinis Evidence of enzootic circulation of West Nile virus (Nea Santa-Greece-2010, lineage 2), Greece, May to July 2011 33 by A Chaskopoulou, CI Dovas, SC Chaintoutis, I Bouzalas, G Ara, M Papanastassopoulou Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011 37 by K Danis, A Papa, E Papanikolaou, G Dougas, I Terzaki, A Baka, G Vrioni, V Kapsimali, A Tsakris, A Kansouzidou, S Tsiodras, N Vakalis, S Bonovas, J Kremastinou West Nile virus: the Italian national transplant network reaction to an alert in the north-eastern region, Italy 2011 42 by A Nanni Costa, MR Capobianchi, G Ippolito, G Palù, L Barzon, G Piccolo, B Andreetta, M Filippetti, D Fehily, L Lombardini, P Grossi This is a photograph of the Asian tiger mosquito, Aedes albopictus. An epidemiologically important vector, Aedes albopictus, from the Culicidae family, may transmit several viral pathogens, including West Nile virus and Dengue virus. © Istockphoto www.eurosurveillance.org 1 Surveillance and outbreak reports Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009 P Pezzotti ([email protected])1, C Piovesan2, L Barzon3,4, R Cusinato4, M Cattai4, M Pacenti4, A Piazza4, E Franchin3,4, S Pagni3,4, S Bressan4, T Martello4, R Potenza5, C Scipioni5, R Ammendola5, A Breda6, G Palù3,4, F Russo2, G Rezza7 1. Lazio Sanità – Agenzia di Sanità Pubblica (Public Health Agency), Rome, Italy 2. Direction of Prevention, Veneto region, Venice, Italy 3. Department of Histology, Microbiology, and Medical Biotechnologies, University of Padua, Padua, Italy 4. Regional Reference Centre for Infectious Diseases, Microbiology and Virology Unit, Hospital of Padua, Padua, Italy 5. Dipartimento Interaziendale di Medicina Trasfusionale (DIMT; Interinstitutional Department of Transfusion Medicine), Local Health Unit AUSL 18-19, Rovigo, Italy 6. Coordinamento Regionale per le Attività Trasfusionali (CRAT; Regional office for the coordination of blood transfusions), Pieve di Soligo, Italy 7. Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy Citation style for this article: Pezzotti P, Piovesan C, Barzon L, Cusinato R, Cattai M, Pacenti M, Piazza A, Franchin E, Pagni S, Bressan S, Martello T, Potenza R, Scipioni C, Ammendola R, Breda A, Palù G, Russo F, Rezza G. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009 . Euro Surveill. 2011;16(10):pii=19814. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19814 Article published on 10 March 2011 Following reports of West Nile neuroinvasive disease During the last 20 years, several WNV outbreaks have in the north-eastern area of Italy in 2009, all blood occurred throughout the world. In addition to the donations dating from the period between 1 August United States [7], where the virus was first identified and 31 October 2009 in the Rovigo province of the in 1999 [2,3,6], large WNV outbreaks have also been Veneto region were routinely checked to exclude those reported in Europe and in the Mediterranean basin with a positive nucleic acid test for West Nile virus [8,9]. The largest European outbreak occurred in 1996 (WNV). Only one of 5,726 blood donations was positive in Bucharest, Romania [10]. In the Mediterranean area, (17.5 per 100,000 donations; 95% confidence interval the first outbreak of human encephalitis was identi- (CI): 0.4–97.3). In addition, a selection of 2,507 blood fied in the Camargue, France, in 1962 [11], followed donations collected during the period from 20 July to by other epidemics in the 1990s involving a relatively 15 November 2009
Load more

Recommended publications
  • Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses
    ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES 7/31/2017 Arizona Department of Health Services | P a g e 1 Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses OBJECTIVES .............................................................................................................. 4 I: CHIKUNGUNYA ..................................................................................................... 5 Chikungunya Ecology and Transmission ....................................... 6 Chikungunya Clinical Disease and Case Management ............... 7 Chikungunya Laboratory Testing .................................................. 8 Chikungunya Case Definitions ...................................................... 9 Chikungunya Case Classification Algorithm ............................... 11 II: DENGUE .............................................................................................................. 12 Dengue Ecology and Transmission .............................................. 14 Dengue Clinical Disease and Case Management ...................... 14 Dengue Laboratory Testing ......................................................... 17 Dengue Case Definitions ............................................................ 19 Dengue Case Classification Algorithm ....................................... 23 III: ZIKA ..................................................................................................................
    [Show full text]
  • Table of Contents
    Table of contents Proposed name of the Biosphere Reserve ........................................................................................... 3 Country ................................................................................................................................................. 3 Fulfilment of the three functions of biosphere reserves ..................................................................... 3 Criteria for designation as a Biosphere Reserve .................................................................................. 6 Endorsements .................................................................................................................................... 21 Location (coordinates and maps) ....................................................................................................... 21 Area .................................................................................................................................................... 22 Biogeographical region ...................................................................................................................... 24 Land use history ................................................................................................................................. 25 Human population of proposed Biosphere Reserve .......................................................................... 28 Physical characteristics ......................................................................................................................
    [Show full text]
  • Executive Orders and Emergency Declarations for the West Nile Virus: Applying Lessons from Past Outbreaks to Zika
    Executive Orders and Emergency Declarations for the West Nile Virus: Applying Lessons from Past Outbreaks to Zika Government leaders are often given the authority to issue executive orders (EOs), proclamations, or emergency declarations to address public health threats, such as that posed by the Zika virus.1 Local, state, and federal executive branch leaders have used these powers to address public health threats posed by other mosquito-borne diseases.2 While existing laws and regulations may allow localities, states, and the federal government to take action to combat mosquito-borne threats absent an EO or emergency declaration, examining such executive actions provides a snapshot of how some jurisdictions have responded to past outbreaks. As of February 21, 2016, only one territory and two states (Puerto Rico, Florida, and Hawaii) have issued emergency declarations that contemplate the threats posed by the Zika virus.3, 4 Historically, however, many US jurisdictions have taken such actions to address other mosquito-borne illnesses, such as West Nile virus. The following provides a brief analysis of select uses of local, state, and federal executive powers to combat West Nile virus. Examining the use of executive powers to address West 1 L Rutkow et al. The Public Health Workforce and Willingness to Respond to Emergencies: A 50-State Analysis of Potentially Influential Laws, 42 J. LAW MED. & ETHICS 64, 64 (2014) (“In the United States, at the federal, state, and local levels, laws provide an infrastructure for public health emergency preparedness and response efforts. Law is perhaps most visible during an emergency when the president or a state’s governor issues a disaster declaration establishing the temporal and geographic parameters for the response and making financial and other resources available.”).
    [Show full text]
  • Rift Valley and West Nile Virus Antibodies in Camels, North Africa
    LETTERS 4°75′Ε) during May–June 2010. All 2. Fijan N, Matasin Z, Petrinec Z, Val- Rift Valley and larvae were euthanized as part of an potiç I, Zwillenberg LO. Isolation of an iridovirus-like agent from the green frog West Nile Virus invasive species eradication project (Rana esculenta L.). Vet Arch Zagreb. and stored at –20°C until further 1991;3:151–8. Antibodies use. At necropsy, liver tissues were 3. Cunningham AA, Langton TES, Bennet in Camels, collected, and DNA was extracted PM, Lewin JF, Drury SEN, Gough RE, et al. Pathological and microbiological North Africa by using the Genomic DNA Mini fi ndings from incidents of unusual mor- Kit (BIOLINE, London, UK). PCR tality of the common frog (Rana tempo- To the Editor: Different to detect ranavirus was performed as raria). Philos Trans R Soc Lond B Biol arboviral diseases have expanded described by Mao et al. (10). Sci. 1996;351:1539–57. doi:10.1098/ rstb.1996.0140 their geographic range in recent times. Three samples showed positive 4. Hyatt AD, Gould AR, Zupanovic Z, Of them, Rift Valley fever, West Nile results with this PCR. These samples Cunningham AA, Hengstberger S, Whit- fever, and African horse sickness were sequenced by using primers tington RJ, et al. Comparative studies of are of particular concern. They are M4 and M5 described by Mao et al. piscine and amphibian iridoviruses. Arch Virol. 2000;145:301–31. doi:10.1007/ endemic to sub-Saharan Africa but (10) and blasted in GenBank. A 100% s007050050025 occasionally spread beyond this area.
    [Show full text]
  • Dengue Fever and Dengue Hemorrhagic Fever (Dhf)
    DENGUE FEVER AND DENGUE HEMORRHAGIC FEVER (DHF) What are DENGUE and DHF? Dengue and DHF are viral diseases transmitted by mosquitoes in tropical and subtropical regions of the world. Cases of dengue and DHF are confirmed every year in travelers returning to the United States after visits to regions such as the South Pacific, Asia, the Caribbean, the Americas and Africa. How is dengue fever spread? Dengue virus is transmitted to people by the bite of an infected mosquito. Dengue cannot be spread directly from person to person. What are the symptoms of dengue fever? The most common symptoms of dengue are high fever for 2–7 days, severe headache, backache, joint pains, nausea and vomiting, eye pain and rash. The rash is frequently not visible in dark-skinned people. Young children typically have a milder illness than older children and adults. Most patients report a non-specific flu-like illness. Many patients infected with dengue will not show any symptoms. DHF is a more severe form of dengue. Initial symptoms are the same as dengue but are followed by bleeding problems such as easy bruising, skin hemorrhages, bleeding from the nose or gums, and possible bleeding of the internal organs. DHF is very rare. How soon after exposure do symptoms appear? Symptoms of dengue can occur from 3-14 days, commonly 4-7 days, after the bite of an infected mosquito. What is the treatment for dengue fever? There is no specific treatment for dengue. Treatment usually involves treating symptoms such as managing fever, general aches and pains. Persons who have traveled to a tropical or sub-tropical region should consult their physician if they develop symptoms.
    [Show full text]
  • A New Orbivirus Isolated from Mosquitoes in North-Western Australia Shows Antigenic and Genetic Similarity to Corriparta Virus B
    viruses Article A New Orbivirus Isolated from Mosquitoes in North-Western Australia Shows Antigenic and Genetic Similarity to Corriparta Virus but Does Not Replicate in Vertebrate Cells Jessica J. Harrison 1,†, David Warrilow 2,†, Breeanna J. McLean 1, Daniel Watterson 1, Caitlin A. O’Brien 1, Agathe M.G. Colmant 1, Cheryl A. Johansen 3, Ross T. Barnard 1, Sonja Hall-Mendelin 2, Steven S. Davis 4, Roy A. Hall 1 and Jody Hobson-Peters 1,* 1 Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia 4072, Australia; [email protected] (J.J.H.); [email protected] (B.J.M.); [email protected] (D.W.); [email protected] (C.A.O.B.); [email protected] (A.M.G.C.); [email protected] (R.T.B.); [email protected] (R.A.H.) 2 Public Health Virology Laboratory, Department of Health, Queensland Government, P.O. Box 594, Archerfield 4108, Australia; [email protected] (D.W.); [email protected] (S.H.-M.) 3 School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands 6009, Australia; [email protected] 4 Berrimah Veterinary Laboratory, Department of Primary Industries and Fisheries, Darwin 0828, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-7-3365-4648 † These authors contributed equally to the work. Academic Editor: Karyn Johnson Received: 19 February 2016; Accepted: 10 May 2016; Published: 20 May 2016 Abstract: The discovery and characterisation of new mosquito-borne viruses provides valuable information on the biodiversity of vector-borne viruses and important insights into their evolution.
    [Show full text]
  • Your Child Or Family Member May Have Dengue Fever According to Their Clinical History and Physical Examination
    Your child or family member may have dengue fever according to their clinical history and physical examination. If it is dengue, serious complications of the disease can develop. If the complications are recognized early, and a doctor is consulted, it may save the patient’s life. Your doctor can order more tests to see if the patient needs to be hospitalized. The doctor can also order specific tests for dengue, but those tests will take longer than a week for the results to come back. How to Care for the Patient While They Have a Fever: Bed rest. Let patient rest as much as possible. Control the fever. Give acetaminophen or paracetamol (Tylenol) every 6 hours (maximum 4 doses per day). Do not give ibuprofen (Motrin, Advil) aspirin, or aspirin containing drugs. Sponge patient’s skin with cool water if fever stays high. Prevent dehydration which occurs when a person loses too much fluid (from high fevers, vomiting, or poor oral intake). Give plenty of fluids and watch for signs of dehydration. Bring patient to clinic or emergency room if any of the following signs develop: Decrease in urination (check number of wet diapers or trips to the bathroom) Few or no tears when child cries Dry mouth, tongue or lips Sunken eyes Listlessness or overly agitated or confused Fast heart beat (more than 100/min) Cold or clammy fingers and toes Sunken fontanel in infant DO WHILE THE PATIENT HAS FEVER DO WHILE THE PATIENT Prevent spread of dengue within your house. Place patient under bed net or use insect repellent on the patient while they have a fever.
    [Show full text]
  • Wnv-Case-Definition.Pdf
    Draft Case Definition for West Nile Fever Animal and Plant Health Inspection Service West Nile Fever Veterinary Services October 2018 Case Definition (Notifiable) 1. Clinical Signs 1.1 Clinical Signs: West Nile Fever (WNF) is a zoonotic mosquito-borne viral disease caused by the West Nile virus (WNV), a Flavivirus of the family Flaviviridae. Many vertebrate species are susceptible to natural WNV infection; however, fatal neurological outbreaks have only been documented in equids, humans, geese, wild birds (particularly corvids), squirrels, farmed alligators, and dogs. Birds serve as the natural host reservoir of WNV. The incubation period is estimated to be three to 15 days in horses Ten to 39 percent of unvaccinated horses infected with WNV will develop clinical signs. Most clinically affected horses exhibit neurological signs such as ataxia (including stumbling, staggering, wobbly gait, or incoordination) or at least two of the following: circling, hind limb weakness, recumbency or inability to stand (or both), multiple limb paralysis, muscle fasciculation, proprioceptive deficits, altered mental status, blindness, lip droop/paralysis, teeth grinding. Behavioral changes including somnolence, listlessness, apprehension, or periods of hyperexcitability may occur. Other common clinical signs include colic, lameness, anorexia, and fever. 2. Laboratory criteria: 2.1 Agent isolation and identification: The virus can be identified by polymerase chain reaction (PCR) and virus isolation (VI). Preferred tissues from equids are brain or spinal cord. 2.2 Serology: Antibody titers can be identified in paired serum samples by IgM and IgG capture enzyme linked immunosorbent assay (ELISA), plaque reduction neutralization test (PRNT), and virus neutralization (VN). Only a single serum sample is required for IgM capture ELISA, and this is the preferred serologic test in live animals.
    [Show full text]
  • Dengue and Yellow Fever
    GBL42 11/27/03 4:02 PM Page 262 CHAPTER 42 Dengue and Yellow Fever Dengue, 262 Yellow fever, 265 Further reading, 266 While the most important viral haemorrhagic tor (Aedes aegypti) as well as reinfestation of this fevers numerically (dengue and yellow fever) are insect into Central and South America (it was transmitted exclusively by arthropods, other largely eradicated in the 1960s). Other factors arboviral haemorrhagic fevers (Crimean– include intercontinental transport of car tyres Congo and Rift Valley fevers) can also be trans- containing Aedes albopictus eggs, overcrowding mitted directly by body fluids. A third group of of refugee and urban populations and increasing haemorrhagic fever viruses (Lassa, Ebola, Mar- human travel. In hyperendemic areas of Asia, burg) are only transmitted directly, and are not disease is seen mainly in children. transmitted by arthropods at all. The directly Aedes mosquitoes are ‘peri-domestic’: they transmissible viral haemorrhagic fevers are dis- breed in collections of fresh water around the cussed in Chapter 41. house (e.g. water storage jars).They feed on hu- mans (anthrophilic), mainly by day, and feed re- peatedly on different hosts (enhancing their role Dengue as vectors). Dengue virus is numerically the most important Clinical features arbovirus infecting humans, with an estimated Dengue virus may cause a non-specific febrile 100 million cases per year and 2.5 billion people illness or asymptomatic infection, especially in at risk.There are four serotypes of dengue virus, young children. However, there are two main transmitted by Aedes mosquitoes, and it is un- clinical dengue syndromes: dengue fever (DF) usual among arboviruses in that humans are the and dengue haemorrhagic fever (DHF).
    [Show full text]
  • Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021
    Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021 Arbovirus surveillance in Florida includes endemic mosquito-borne viruses such as West Nile virus (WNV), Eastern equine encephalitis virus (EEEV), and St. Louis encephalitis virus (SLEV), as well as exotic viruses such as dengue virus (DENV), chikungunya virus (CHIKV), Zika virus (ZIKV), and California encephalitis group viruses (CEV). Malaria, a parasitic mosquito-borne disease is also included. During the period of March 28- April 3, 2021, the following arboviral activity was recorded in Florida. WNV activity: No human cases of WNV infection were reported this week. No horses with WNV infection were reported this week. No sentinel chickens tested positive for antibodies to WNV this week. In 2021, positive samples from two sentinel chickens has been reported from two counties. SLEV activity: No human cases of SLEV infection were reported this week. No sentinel chickens tested positive for antibodies to SLEV this week. In 2021, no positive samples have been reported. EEEV activity: No human cases of EEEV infection were reported this week. No horses with EEEV infection were reported this week. No sentinel chickens tested positive for antibodies to EEEV this week. In 2021, positive samples from one horse and 14 sentinel chickens have been reported from four counties. International Travel-Associated Dengue Fever Cases: No cases of dengue fever were reported this week in persons that had international travel. In 2021, one travel-associated dengue fever case has been reported. Dengue Fever Cases Acquired in Florida: No cases of locally acquired dengue fever were reported this week. In 2021, no cases of locally acquired dengue fever have been reported.
    [Show full text]
  • National Report 2013 ITALY
    Italian Ministry for the Environment, Land Protection and Sea THIRD UPDATE OF THE NATIONAL REPORT OF ITALY ON THE IMPLEMENTATION OF THE AARHUS CONVENTION January 2014 CERTIFICATION SHEET The following report is submitted on behalf of ITALY in accordance with decisions I/8, II/10 and IV/4. Name of officer responsible for submitting the national report: Corrado Clini, Director General, Ministry for the Environment, Land Protection and Sea (MoE), DG for Sustainable Development, Energy and Climate Signature: Corrado Clini Date: 07/02/2014 IMPLEMENTATION REPORT Please provide the following details on the origin of this report Party National Focal Point Full name of the Institution: Ministry for the Environment, Land Protection and Sea (MoE), DG for Sustainable Development, Energy and Climate Name and title of officer: Valeria Rizzo, Director Postal address: Via C. Colombo 44 - 00147 Rome Telephone:+39 0657228106 Fax: :+39 0657228172 E-mail: [email protected] Contact Officer for National Report (if different): Full name of the Institution: Ministry for the Environment, Territory and Sea (MoE), DG for Sustainable Development, Energy and Climate Name and title of officer: Loredana Dall’Ora - Senior expert Postal address: Via C. Colombo 44- 00147 Rome Telephone: :+39 0657228107 Fax: :+39 0657228172 E-mail: [email protected] IMPLEMENTATION REPORT Italy Based on the reporting format annexed to decisions I/8, II/10 and IV/4 1. Provide brief information on the process by which this report has been prepared, including information on which types of public authorities were consulted or contributed to its preparation, on how the public was consulted and how the outcome of the public consultation was taken into account and on the material, which was used as a basis for preparing the report.
    [Show full text]
  • Rift Valley Fever for Host Innate Immunity in Resistance to a New
    A New Mouse Model Reveals a Critical Role for Host Innate Immunity in Resistance to Rift Valley Fever This information is current as Tânia Zaverucha do Valle, Agnès Billecocq, Laurent of September 25, 2021. Guillemot, Rudi Alberts, Céline Gommet, Robert Geffers, Kátia Calabrese, Klaus Schughart, Michèle Bouloy, Xavier Montagutelli and Jean-Jacques Panthier J Immunol 2010; 185:6146-6156; Prepublished online 11 October 2010; Downloaded from doi: 10.4049/jimmunol.1000949 http://www.jimmunol.org/content/185/10/6146 Supplementary http://www.jimmunol.org/content/suppl/2010/10/12/jimmunol.100094 http://www.jimmunol.org/ Material 9.DC1 References This article cites 46 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/185/10/6146.full#ref-list-1 Why The JI? Submit online. by guest on September 25, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American
    [Show full text]